نتائج البحث 901-910 من 7598 لعملية البحث عن Managing Diabetes-Related Stress
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...
Giving nivolumab, ipilimumab, and radiation therapy may kill more cancer cells. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment ...
... and extracted DNA, and evaluate ctDNA levels at baseline and during treatment for patients with Stage I-III breast cancer. Sapanisertib in Treating Patients ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
Venetoclax is U.S. Food and Drug Administration (FDA) approved for the treatment of CLL and SLL. Pirtobrutinib is currently being studied in patients with CLL ...
... treatment with carboplatine/vincristine (CV) for subjects with NF1-associated low ... The purpose of this study is to determine and compare the safety and ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
... treatment and prevention of a potentially fatal cardiovascular event. This study will be a retrospective and prospective review of medical course and ...
... and Post-transplant Lymphoproliferative Disease (PTLD) after failing first line treatment. ... and 6 cycles, and at progression. We will collect tumor ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.